Yüklüyor......
Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
BACKGROUND: Although established therapies are effective in most patients with generalized myasthenia gravis (gMG), some patients do not respond or they experience intolerable adverse events, highlighting the need for better tolerated, targeted therapies for treatment-refractory gMG. OBJECTIVE: To d...
Kaydedildi:
| Yayımlandı: | J Neuromuscul Dis |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
IOS Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8075396/ https://ncbi.nlm.nih.gov/pubmed/33325394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JND-200584 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|